Peptides  ›  BPC-157  ›  Muscle Growth
Recovery & Repair

BPC-157 for Muscle Growth: What the Research Says

Extensive animal/preclinical research; limited human clinical data.Updated August 2026

BPC-157 (also known as Body Protection Compound 157, PL 14736) is a synthetic peptide widely studied for tissue repair and gut health. This page covers what the published research does — and does not — establish about it in relation to muscle growth and recovery.

What the research covers

BPC-157 is researched for Muscle recovery — which is why it appears in discussions of muscle growth and recovery.

Research status: Extensive animal/preclinical research; limited human clinical data.

How BPC-157 is thought to work

BPC-157 is a synthetic fragment derived from a protective protein found in gastric juice. In animal research it appears to promote angiogenesis (new blood-vessel formation) and to modulate growth-factor and nitric-oxide pathways involved in healing, which is why so much of the literature focuses on tendon, ligament, muscle and gut-lining repair. It is also studied for its stabilizing effects on the gastrointestinal tract.

What it does not establish

Most evidence comes from rodent studies. Long-term human safety data is limited. Not approved as a drug in most jurisdictions.

Nothing on this page is a recommendation to use BPC-157, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.

Commonly researched alongside

A fragment related to Thymosin Beta-4 studied for recovery and flexibility.

KPV

A short tripeptide fragment of α-MSH studied for anti-inflammatory effects.

Other peptides researched for Muscle Growth

A fragment related to Thymosin Beta-4 studied for recovery and flexibility.

A growth-hormone-releasing hormone analog studied for GH support.

A selective growth-hormone secretagogue studied for its clean GH-release profile.

An orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1.

A long-acting analog of insulin-like growth factor 1 studied for growth signaling.

A PEGylated splice variant of IGF-1 studied for muscle repair.

Frequently asked questions

Extensive animal/preclinical research; limited human clinical data. Research relevant to this area covers muscle recovery. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.

Extensive animal/preclinical research; limited human clinical data.

Most evidence comes from rodent studies. Long-term human safety data is limited. Not approved as a drug in most jurisdictions. Always speak to a licensed healthcare professional before considering any peptide.

Most studies look at soft-tissue and gastrointestinal healing — tendons, ligaments, muscle, and the gut lining — along with anti-inflammatory effects. The bulk of this evidence comes from animal models.

No. BPC-157 is not an approved drug in most jurisdictions and human clinical data is limited. The research is largely preclinical, so its effects and safety in people are not established.

Is BPC-157 right for your situation?

Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.

Ask the Advisor — free

This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.